Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Hyaluronan control of the primary vascular barrier during early mouse pregnancy is mediated by uterine NK cells
Ron Hadas, Eran Gershon, Aviad Cohen, Ofir Atrakchi, Shlomi Lazar, Ofra Golani, Bareket Dassa, Michal Elbaz, Gadi Cohen, Raya Eilam, Nava Dekel, Michal Neeman
Ron Hadas, Eran Gershon, Aviad Cohen, Ofir Atrakchi, Shlomi Lazar, Ofra Golani, Bareket Dassa, Michal Elbaz, Gadi Cohen, Raya Eilam, Nava Dekel, Michal Neeman
View: Text | PDF
Research Article Angiogenesis Reproductive biology

Hyaluronan control of the primary vascular barrier during early mouse pregnancy is mediated by uterine NK cells

  • Text
  • PDF
Abstract

Successful implantation is associated with a unique spatial pattern of vascular remodeling, characterized by profound peripheral neovascularization surrounding a periembryo avascular niche. We hypothesized that hyaluronan controls the formation of this distinctive vascular pattern encompassing the embryo. This hypothesis was evaluated by genetic modification of hyaluronan metabolism, specifically targeted to embryonic trophoblast cells. The outcome of altered hyaluronan deposition on uterine vascular remodeling and postimplantation development were analyzed by MRI, detailed histological examinations, and RNA sequencing of uterine NK cells. Our experiments revealed that disruption of hyaluronan synthesis, as well as its increased cleavage at the embryonic niche, impaired implantation by induction of decidual vascular permeability, defective vascular sinus folds formation, breach of the maternal-embryo barrier, elevated MMP-9 expression, and interrupted uterine NK cell recruitment and function. Conversely, enhanced deposition of hyaluronan resulted in the expansion of the maternal-embryo barrier and increased diffusion distance, leading to compromised implantation. The deposition of hyaluronan at the embryonic niche is regulated by progesterone-progesterone receptor signaling. These results demonstrate a pivotal role for hyaluronan in successful pregnancy by fine-tuning the periembryo avascular niche and maternal vascular morphogenesis.

Authors

Ron Hadas, Eran Gershon, Aviad Cohen, Ofir Atrakchi, Shlomi Lazar, Ofra Golani, Bareket Dassa, Michal Elbaz, Gadi Cohen, Raya Eilam, Nava Dekel, Michal Neeman

×

Figure 4

Genetic modifications in embryonic trophoblast cells.

Options: View larger image (or click on image) Download as PowerPoint
Genetic modifications in embryonic trophoblast cells.
(A) Morulae were r...
(A) Morulae were retrieved from pregnant mice (E2.5), grown to blastocysts, infected with lentiviral vectors, and transferred to pseudopregnant mice. Immediately thereafter, Hyal-2 was overexpressed in the trophectoderm. (B) eGFP expression prior to embryo transfer. (C–E) Maximal intensity projections of whole-mount immunofluorescence for Hyal-2 in blastocysts following lentiviral transduction prior to embryo transfer, blastocysts over-expressing HAS-2 in their trophectoderm visualized for eGFP expression, and HAS-2 overexpression following viral infection. (F) Validation of Hyal-2 and HAS-2 overexpression by Western blot analysis. (G) Quantification of Western blot analysis following infection with lentiviral vectors. (H) Histological assessment of hyaluronan deposition as a result of Hyal-2 and HAS-2 overexpression. (n = 3 mice). (I) E6.5 trophoblast cells exclusively expressing eGFP alongside the WT epiblast and endoderm.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts